
Free Daily Podcast Summary
by Colabra
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
The most recent episodes — sign up to get AI-powered summaries of each one.
Severe burns require specialized care and long healing times at great expense. This week's Talking Biotech podcast explores the latest advancements in burn treatment technology with Dr. Katie Bush from Aveda Medical. Discover how innovative cell therapies and regenerative techniques are transforming wound healing, reducing hospital stays, and improving cosmetic outcomes.00:00Introduction to Burn Care Innovations02:13Understanding Burn Physiology05:18Challenges in Traditional Burn Treatments08:04Revolutionizing Burn Treatment with Resell Technology11:06Mechanisms of Resell Technology14:04Operational Impact on Burn Centers16:42Exploring Additional Applications of Resell19:37Future Directions in Burn Care Technology
This episode explores the latest advancements in personalized DNA and RNA technologies for early cancer detection, diagnostics, and treatment monitoring. Dr. Nathan Montgomery from Neo Genomics Laboratories discusses how molecular residual disease testing, liquid biopsies, and genomic sequencing are transforming oncology care.
Chronic kidney disease (CKD) is a pressing health issue that affects over a billion people worldwide, yet it often goes unnoticed until it's too late. In this post, we'll explore insights from Dr. Salvadore Viscomi, the CEO and founder of Carna Health, who sheds light on the alarming prevalence of CKD, its underlying causes, and the innovative solutions being implemented to address this global health crisis.Resources & Links:Carna Health Official WebsiteLinkedIn Profile of Salvadore ViscomiSiemens Biomarker Testing SolutionsFDA Clearances for Point of Care Testing DevicesConnect with Dr. Salvador Viscome:LinkedInTwitter
This week's Talking Biotech Podcast examines the realistic potential of AI in cancer research and healthcare, emphasizing data quality, individualization, and system reform. Guest: Dr. Emilia Javorsky, Future of Life Institute. Future of Life InstituteAI and Cancer: A New Frontier
This episode explores the pioneering work on ice minus bacteria and their role in frost damage prevention in plants. Dr. Steven Lindow shares insights into early biotech innovations, regulatory challenges, and the potential for modern applications of this technology.
In this episode of the Talking Biotech podcast, Dr. Karsten Eastman discusses the significance of peptides in biology and their therapeutic potential. He explains the roles of peptides, particularly GLP-1 therapeutics, and the challenges associated with their stability and bioavailability. The conversation delves into nature's strategies for enhancing peptide stability and how Sathera Therapeutics is innovating in this space to create more effective peptide-based therapies. The discussion also touches on the business model of Sathera and its focus on rare cancers and anti-inflammatory treatments.
In this episode of the Talking Biotech podcast, Dr. Danelle Seymour discusses the genetic anomoliies observed in the vegetative propagation of tree crops, particularly citrus. The conversation delves into the importance of preserving genetic material through grafting, the challenges of genetic variation in vegetatively propagated plants, and the role of mutations in these processes. Dr. Seymour shares insights from her research on the historic Washington Naval orange tree and the implications of somatic mutations for breeding and disease resistance in citrus.
In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Talking Biotech with Dr. Kevin Folta in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Talking Biotech with Dr. Kevin Folta as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Colabra.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
Talking Biotech with Dr. Kevin Folta publishes weekly. Our AI generates a summary within hours of each new episode.
Talking Biotech with Dr. Kevin Folta covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.